CL2023000823A1 - Métodos para tratar trastornos asociados a la vía del receptor de melanocortina 4 - Google Patents
Métodos para tratar trastornos asociados a la vía del receptor de melanocortina 4Info
- Publication number
- CL2023000823A1 CL2023000823A1 CL2023000823A CL2023000823A CL2023000823A1 CL 2023000823 A1 CL2023000823 A1 CL 2023000823A1 CL 2023000823 A CL2023000823 A CL 2023000823A CL 2023000823 A CL2023000823 A CL 2023000823A CL 2023000823 A1 CL2023000823 A1 CL 2023000823A1
- Authority
- CL
- Chile
- Prior art keywords
- melanocortin
- methods
- disorders associated
- treat disorders
- receptor pathway
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063082867P | 2020-09-24 | 2020-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023000823A1 true CL2023000823A1 (es) | 2023-09-15 |
Family
ID=80845850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023000823A CL2023000823A1 (es) | 2020-09-24 | 2023-03-22 | Métodos para tratar trastornos asociados a la vía del receptor de melanocortina 4 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240058414A1 (https=) |
| EP (1) | EP4216979A4 (https=) |
| JP (1) | JP2023542985A (https=) |
| KR (1) | KR20230095956A (https=) |
| CN (1) | CN116507353A (https=) |
| AR (1) | AR123603A1 (https=) |
| AU (1) | AU2021350017A1 (https=) |
| CA (1) | CA3192873A1 (https=) |
| CL (1) | CL2023000823A1 (https=) |
| CO (1) | CO2022009561A2 (https=) |
| MX (1) | MX2023003360A (https=) |
| TW (1) | TW202228760A (https=) |
| WO (1) | WO2022067086A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023308310A1 (en) * | 2022-07-12 | 2025-01-16 | Rhythm Pharmaceuticals, Inc. | Methods for treating obesity with an mc4r agonist |
| EP4618952A2 (en) * | 2022-11-18 | 2025-09-24 | Rhythm Pharmaceuticals, Inc. | Methods for treating obesity with an mc4r agonist |
| WO2025106751A1 (en) * | 2023-11-14 | 2025-05-22 | Rhythm Pharmaceuticals, Inc. | Combinations of a potassium channel activator and an mc4r agonist and related methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2286825T3 (pl) * | 2005-07-08 | 2017-06-30 | Ipsen Pharma | Ligandy receptora melanokortyny |
| RU2020120797A (ru) * | 2013-03-15 | 2020-07-02 | Ритм Фармасьютикалз, Инк. | Пептидные композиции |
| MA43040A (fr) * | 2015-09-30 | 2018-08-08 | Univ Berlin Charite | Méthode de traitement de troubles associés à la voie du récepteur de la mélanocortine 4 |
-
2021
- 2021-09-24 EP EP21873549.6A patent/EP4216979A4/en active Pending
- 2021-09-24 TW TW110135665A patent/TW202228760A/zh unknown
- 2021-09-24 JP JP2023518779A patent/JP2023542985A/ja active Pending
- 2021-09-24 CA CA3192873A patent/CA3192873A1/en active Pending
- 2021-09-24 AU AU2021350017A patent/AU2021350017A1/en active Pending
- 2021-09-24 MX MX2023003360A patent/MX2023003360A/es unknown
- 2021-09-24 WO PCT/US2021/052032 patent/WO2022067086A1/en not_active Ceased
- 2021-09-24 US US18/028,117 patent/US20240058414A1/en active Pending
- 2021-09-24 KR KR1020237013822A patent/KR20230095956A/ko active Pending
- 2021-09-24 CN CN202180071771.8A patent/CN116507353A/zh active Pending
- 2021-09-24 AR ARP210102664A patent/AR123603A1/es unknown
-
2022
- 2022-07-07 CO CONC2022/0009561A patent/CO2022009561A2/es unknown
-
2023
- 2023-03-22 CL CL2023000823A patent/CL2023000823A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021350017A1 (en) | 2023-05-04 |
| JP2023542985A (ja) | 2023-10-12 |
| AU2021350017A9 (en) | 2024-10-03 |
| MX2023003360A (es) | 2023-06-23 |
| US20240058414A1 (en) | 2024-02-22 |
| EP4216979A1 (en) | 2023-08-02 |
| WO2022067086A1 (en) | 2022-03-31 |
| CN116507353A (zh) | 2023-07-28 |
| EP4216979A4 (en) | 2024-11-06 |
| AR123603A1 (es) | 2022-12-21 |
| CO2022009561A2 (es) | 2022-07-19 |
| CA3192873A1 (en) | 2022-03-31 |
| KR20230095956A (ko) | 2023-06-29 |
| TW202228760A (zh) | 2022-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000823A1 (es) | Métodos para tratar trastornos asociados a la vía del receptor de melanocortina 4 | |
| CL2022001256A1 (es) | Métodos y composiciones para tratar un trastorno asociado con el angiotensinogeno agt | |
| Gressier et al. | 5-HTTLPR and gender differences in affective disorders: a systematic review | |
| SA522432294B1 (ar) | نظام وعملية للتكسير بالبخار ومعالجة زيت وقود الانحلال الحراري تتضمن الهدرجة الانتقائية والتكسير بالهيدروجين انتقائياً | |
| SA522432291B1 (ar) | نظام وعملية للتكسير بالبخار ومعالجة زيت وقود الانحلال الحراري تتضمن الهدرجة الانتقائية والتكسير بالهيدروجين وإعادة تشكيل النفثا | |
| CO2021008998A2 (es) | Amidas de pirrolidina iii sustituidas | |
| ZA201903091B (en) | Methods of treating inflammatory conditions | |
| PH12022551646A1 (en) | Methods for treating pemphigus disorders | |
| MX2016015126A (es) | Composiciones de angiotensinogeno (agt) arni y metodos de uso de las mismas. | |
| GT201600227A (es) | Vectores de aav para la terapia génica de la retina y el snc | |
| EP4360704A3 (en) | Method of treating melanocortin-4 receptor pathway-associated disorders | |
| ES3060591T3 (en) | Modified polymerases for improved incorporation of nucleotide analogues | |
| UY32449A (es) | Benzazepinas fusionadas como ligandos de receptor de acetilcolina nicotínico neuronal | |
| PH12017502120A1 (en) | A method and an apparatus for forming a lignin fraction, a lignin composition and its use | |
| CL2020001936A1 (es) | Métodos para el tratamiento de la atrofía muscular espinal. | |
| ECSP23076906A (es) | Composiciones y métodos para inhibir cetohexoquinasa (khk) | |
| CO2024007225A2 (es) | Tratamiento de trastornos hepáticos con un agonista del thr-β | |
| BR112022015015A2 (pt) | Usos terapêuticos de tirzepatida | |
| CU20200038A7 (es) | Compuestos derivados de pirazolo-pirrolo-pirimidina-diona como inhibidores de p2x3 | |
| MX2025004103A (es) | Metodos de identificacion de pacientes con posibilidad de beneficiarse de un tratamiento con un inhibidor de la telomerasa | |
| DOP2011000209A (es) | Compuestos de quinazolina sustituidos | |
| MX2017011885A (es) | Uso de antagonistas de receptores de glucocorticoides en combinacion con glucocorticoides para tratar la insuficiencia adrenal. | |
| MX2023005408A (es) | Compuestos y su uso en el tratamiento de trastornos mediados por el receptor de taquiquinina. | |
| UY40350A (es) | Métodos para el tratamiento de la obesidad con un agonista mc4r | |
| CL2025002297A1 (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa. |